Float Short %

8.01

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

-0.41

EPS Last/This Y

0.11

EPS This/Next Y

0.45

Price

41.23

Target Price

63.75

Analyst Recom

Performance Q

-26.83

Relative Volume

0.77

Beta

1.3

Ticker: VCEL

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-21	VCEL	46.29	0.12	0.20	983
2025-03-24	VCEL	47.9	0.12	0.22	913
2025-03-25	VCEL	48.02	0.12	0.17	919
2025-03-26	VCEL	46.41	0.12	0.11	933
2025-03-27	VCEL	45.95	0.12	0.75	948
2025-03-28	VCEL	44.46	0.12	3.00	951
2025-03-31	VCEL	44.62	0.12	999.99	953
2025-04-01	VCEL	43.08	0.12	0.04	954
2025-04-02	VCEL	44.39	0.13	0.41	1022
2025-04-03	VCEL	43.47	0.13	0.41	1022
2025-04-04	VCEL	41.89	0.13	999.99	1029
2025-04-07	VCEL	39.9	0.13	0.31	1029
2025-04-08	VCEL	38.63	0.14	0.00	1060
2025-04-09	VCEL	44.32	0.14	999.99	1073
2025-04-10	VCEL	41.8	0.14	999.99	1073
2025-04-11	VCEL	41.17	0.14	0.00	1074
2025-04-14	VCEL	41.17	0.14	0.00	1078
2025-04-15	VCEL	42.07	0.14	0.00	1078
2025-04-16	VCEL	40.85	0.14	0.17	1081
2025-04-17	VCEL	41.26	0.14	999.99	1087
2025-04-18	VCEL	41.23	0.14	1.00	1087
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-21	VCEL	46.29	-67.5	-	0.30
2025-03-24	VCEL	47.94	-67.5	-	0.30
2025-03-25	VCEL	47.96	-67.5	-	0.30
2025-03-26	VCEL	46.42	-67.5	-	0.30
2025-03-27	VCEL	46.07	-67.5	-	0.30
2025-03-28	VCEL	44.50	-67.5	-	0.30
2025-03-31	VCEL	44.62	-67.5	-	0.30
2025-04-01	VCEL	43.08	-67.5	-	0.30
2025-04-02	VCEL	44.31	-67.5	-	0.30
2025-04-03	VCEL	43.49	-67.5	-	0.30
2025-04-04	VCEL	41.80	-67.5	-	0.30
2025-04-07	VCEL	39.89	-67.5	-	0.30
2025-04-08	VCEL	38.60	-67.5	-	0.30
2025-04-09	VCEL	44.24	-67.5	-	0.30
2025-04-10	VCEL	41.92	-67.5	-	0.30
2025-04-11	VCEL	41.22	-67.5	-	0.30
2025-04-14	VCEL	41.23	-67.5	-	0.30
2025-04-15	VCEL	42.01	-67.5	-	0.30
2025-04-16	VCEL	40.85	-67.5	-	0.32
2025-04-17	VCEL	41.23	-91.7	-	0.32
2025-04-18	VCEL	41.23	-91.7	-	0.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-21	VCEL	-29.86	3.48	7.88
2025-03-24	VCEL	-29.79	3.46	7.88
2025-03-25	VCEL	-29.79	3.46	7.88
2025-03-26	VCEL	-29.79	3.46	7.15
2025-03-27	VCEL	-29.79	3.46	7.15
2025-03-28	VCEL	-29.79	3.46	7.15
2025-03-31	VCEL	-29.79	3.47	7.15
2025-04-01	VCEL	-29.79	3.47	7.15
2025-04-02	VCEL	-29.79	3.47	7.15
2025-04-03	VCEL	-29.74	3.47	7.15
2025-04-04	VCEL	-29.74	3.47	7.15
2025-04-07	VCEL	-29.19	3.13	7.15
2025-04-08	VCEL	-29.19	3.13	7.15
2025-04-09	VCEL	-29.19	3.13	7.15
2025-04-10	VCEL	-29.19	3.13	8.01
2025-04-11	VCEL	-29.19	3.13	8.01
2025-04-14	VCEL	-33.62	3.15	8.01
2025-04-15	VCEL	-33.62	3.15	8.01
2025-04-16	VCEL	-33.62	3.15	8.01
2025-04-17	VCEL	-33.62	3.15	8.01
2025-04-18	VCEL	-33.62	3.15	8.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.38

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-33.62

Institutional Transactions

3.15

Beta

1.3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

40.2

Max Drawdown 5-Year %

-74

Target Price

63.75

P/E

223.35

Forward P/E

55.56

PEG

2.62

P/S

8.71

P/B

7.01

P/Free Cash Flow

EPS

0.18

Average EPS Est. Cur. Y

0.32

EPS Next Y. (Est.)

0.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.37

Relative Volume

0.77

Return on Equity vs Sector %

-16.4

Return on Equity vs Industry %

-3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Vericel Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 357

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

stock quote shares VCEL – Vericel Corporation Stock Price stock today

news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch VCEL – Vericel Corporation yahoo finance google finance

stock history VCEL – Vericel Corporation invest stock market

stock prices VCEL premarket after hours

ticker VCEL fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VCEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y